ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment. | Breast J;20(1): 37-45, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment.

Park, MiHee M; Ebel, Joshua J; Zhao, Weiquiang; Zynger, Debra L.

Affiliation

Park MM; Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio.

Breast J ; 20(1): 37-45, 2014.

Article in En | MEDLINE | ID: mdl-24261318

Subject(s)
Key words

RT-PCR; breast cancer; estrogen receptor; human epidermal growth factor; immunohistochemistry; oncotype DX

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Biomarkers, Tumor / Receptor, ErbB-2 Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2014 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Biomarkers, Tumor / Receptor, ErbB-2 Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2014 Document type: Article